Cargando…

Lansoprazole promotes cisplatin‐induced acute kidney injury via enhancing tubular necroptosis

Acute kidney injury (AKI) is the main obstacle that limits the use of cisplatin in cancer treatment. Proton pump inhibitors (PPIs), the most commonly used class of medications for gastrointestinal complications in cancer patients, have been reported to cause adverse renal events. However, the effect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Lin, Pang, Wanxia, Huang, Yanheng, Wu, Hongluan, Huang, Xiaorong, Liu, Jianxing, Wang, Shujun, Yang, Chen, Pan, Qingjun, Liu, Huafeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933939/ https://www.ncbi.nlm.nih.gov/pubmed/33605079 http://dx.doi.org/10.1111/jcmm.16302

Ejemplares similares

Role of Transcription Factor EB in Mitochondrial Dysfunction of Cisplatin-Induced Acute Kidney Injury
por: Wang, Shujun, et al.
Publicado: (2023)

Repositioning of Lansoprazole as a Protective Agent Against Cisplatin-Induced Ototoxicity
por: Wakai, Eri, et al.
Publicado: (2022)

Lansoprazole-Induced Improvement of Esophageal Submucosal Injury
por: Mine, Shinichiro, et al.
Publicado: (2007)

Activation of Transcription Factor EB Alleviates Tubular Epithelial Cell Injury via Restoring Lysosomal Homeostasis in Diabetic Nephropathy
por: Wang, Shujun, et al.
Publicado: (2022)

Melatonin Attenuates Cisplatin-Induced Acute Kidney Injury through Dual Suppression of Apoptosis and Necroptosis
por: Kim, Jong Woo, et al.
Publicado: (2019)

VPA improves ferroptosis in tubular epithelial cells after cisplatin-induced acute kidney injury
por: Li, Yan, et al.
Publicado: (2023)

Artesunate relieves acute kidney injury through inhibiting macrophagic Mincle‐mediated necroptosis and inflammation to tubular epithelial cell
por: Lei, Xian‐ying, et al.
Publicado: (2021)

Autophagy and necroptosis in cisplatin-induced acute kidney injury: Recent advances regarding their role and therapeutic potential
por: Alassaf, Noha, et al.
Publicado: (2023)

PSTPIP2 inhibits cisplatin-induced acute kidney injury by suppressing apoptosis of renal tubular epithelial cells
por: Zhu, Hong, et al.
Publicado: (2020)

Nephropathy Is Aggravated by Fatty Acids in Diabetic Kidney Disease through Tubular Epithelial Cell Necroptosis and Is Alleviated by an RIPK-1 Inhibitor
por: Yu, Qi, et al.
Publicado: (2023)

Autophagy activation reduces renal tubular injury induced by urinary proteins
por: Liu, Wei Jing, et al.
Publicado: (2014)

The pathological role of damaged organelles in renal tubular epithelial cells in the progression of acute kidney injury
por: Li, Zixian, et al.
Publicado: (2022)

Immune and Inflammatory Responses in GERD and Lansoprazole
por: Isomoto, Hajime, et al.
Publicado: (2007)

Toxic epidermal necrolysis induced by lansoprazole()
por: Fracaroli, Tainá Scalfoni, et al.
Publicado: (2013)

Dynamics of necroptosis in kidney ischemia-reperfusion injury
por: Pefanis, Aspasia, et al.
Publicado: (2023)

AT1 and AT2 receptors modulate renal tubular cell necroptosis in angiotensin II-infused renal injury mice
por: Zhu, Yongjun, et al.
Publicado: (2019)

Metformin Protects Against Cisplatin-Induced Tubular Cell Apoptosis and Acute Kidney Injury via AMPKα-regulated Autophagy Induction
por: Li, Jianzhong, et al.
Publicado: (2016)

High-Fat Diet-Induced Renal Proximal Tubular Inflammatory Injury: Emerging Risk Factor of Chronic Kidney Disease
por: Chen, Shuxian, et al.
Publicado: (2021)

High Glucose-Induced Kidney Injury via Activation of Necroptosis in Diabetic Kidney Disease
por: Guo, Man, et al.
Publicado: (2023)

Valproic acid treatment attenuates cisplatin‐induced kidney injury by suppressing proximal tubular cell damage
por: Yoshioka, Toshihiko, et al.
Publicado: (2023)

Histone deacetylase inhibitors protect against cisplatin-induced acute kidney injury by activating autophagy in proximal tubular cells
por: Liu, Jing, et al.
Publicado: (2018)

Hypoxia-reoxygenation induced necroptosis in cultured rat renal tubular epithelial cell line
por: Zhu, Changlai, et al.
Publicado: (2018)

Mechanisms and Functions of Mitophagy and Potential Roles in Renal Disease
por: Zuo, Zhenying, et al.
Publicado: (2020)

Prevention of NSAID-Induced Small Intestinal Mucosal Injury: Prophylactic Potential of Lansoprazole
por: Higuchi, Kazuhide, et al.
Publicado: (2009)

MiR-519d represses ovarian cancer cell proliferation and enhances cisplatin-mediated cytotoxicity in vitro by targeting XIAP
por: Pang, Yingxin, et al.
Publicado: (2014)

Necroptosis in acute kidney injury: a shedding light
por: Wang, S, et al.
Publicado: (2016)

The Expression of Heme Oxygenase-1 Induced by Lansoprazole
por: Takagi, Tomohisa, et al.
Publicado: (2009)

Berberine in combination with cisplatin induces necroptosis and apoptosis in ovarian cancer cells
por: Liu, Li, et al.
Publicado: (2019)

PACS-2 deficiency aggravates tubular injury in diabetic kidney disease by inhibiting ER-phagy
por: Yang, Jinfei, et al.
Publicado: (2023)

Lansoprazole protects hepatic cells against cisplatin-induced oxidative stress through the p38 MAPK/ARE/Nrf2 pathway
por: Yamagishi, Naoko, et al.
Publicado: (2023)

Lansoprazole attenuates cyclophosphamide-induced cardiopulmonary injury by modulating redox-sensitive pathways and inflammation
por: Hassanein, Emad H. M., et al.
Publicado: (2023)

Panduratin A Derivative Protects against Cisplatin-Induced Apoptosis of Renal Proximal Tubular Cells and Kidney Injury in Mice
por: Thongnuanjan, Penjai, et al.
Publicado: (2021)

Canagliflozin protects against cisplatin-induced acute kidney injury by AMPK-mediated autophagy in renal proximal tubular cells
por: Park, Cheol Ho, et al.
Publicado: (2022)

Tubular aryl hydratocarbon receptor upregulates EZH2 to promote cellular senescence in cisplatin-induced acute kidney injury
por: Wen, Li, et al.
Publicado: (2023)

Tubular cell senescence promotes maladaptive kidney repair and chronic kidney disease after cisplatin nephrotoxicity
por: Li, Siyao, et al.
Publicado: (2023)

Toxic epidermal necrolysis induced by Lansoprazole: Pharmacologic considerations*
por: Gomes, Ciro Martins
Publicado: (2013)

Lansoprazole is an antituberculous prodrug targeting cytochrome bc(1)
por: Rybniker, Jan, et al.
Publicado: (2015)

Ingestibility and Formulation Quality of Lansoprazole Orally Disintegrating Tablets
por: Chono, Sumio, et al.
Publicado: (2016)

Lansoprazole as an uncommon cause of anaphylaxis: What to give next?
por: Aydin, Ali Attila, et al.
Publicado: (2018)

Triggering necroptosis in cisplatin and IAP antagonist-resistant ovarian carcinoma
por: McCabe, K E, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_vmojvqncbrrb5dcj354bbsc79m